Pfizer Lawsuit Over Celebrex, Bextra Safety Sent Back to Lower Court
Pfizer is facing a lawsuit that had been revived 12 years after. The New York-based company is being sued by shareholders of the company, who claimed that they were not informed of the cardiovascular risks of Celebrex and Bextra. The shareholders suffered substantial amount of losses.